gamma-Tocotrienol, a member of the
vitamin E family of compounds, induces apoptosis in a variety of
cancer cell types. However, previous studies have clearly demonstrated that
gamma-tocotrienol-induced apoptosis in neoplastic mouse +SA mammary epithelial cells is not mediated through mitochondrial stress or
death receptor apoptotic signaling. Therefore, studies were conducted to determine the role of endoplasmic reticulum (ER) stress in mediating
gamma-tocotrienol-induced apoptosis in +SA mammary
tumor cells. Treatment with 15-40 microM
gamma-tocotrienol induced +SA cell death in a dose-responsive manner, and these effects were associated with a corresponding increase in
poly (ADP-ribose) polymerase (PARP)-cleavage and activation of
protein kinase-like endoplasmic reticulum
kinase/eukaryotic translational
initiation factor/
activating transcription factor 4 (PERK/eIF2alpha/ATF-4) pathway, a marker of ER stress response. These treatments also caused a large increase in
C/EBP homologous protein (CHOP) levels, a key component of ER stress mediated apoptosis that increases expression of tribbles 3 (TRB3). Knockdown of CHOP by specific siRNAs attenuated
gamma-tocotrienol-induced PARP-cleavage, CHOP and TRB3 expression.
gamma-Tocotrienol treatment also reduced full-length
caspase-12 levels, an indication of
caspase-12 cleavage and activation. Intracellular levels of
3-hydroxy-3-methylglutaryl-coenzyme A (HMGCoA)
reductase, an ER-transmembrane
enzyme catalyzing the synthesis of
mevalonate, decreased following
gamma-tocotrienol treatment, but combined treatment with
mevalonate did not reverse
gamma-tocotrienol-induced apoptosis, suggesting that a decrease in HMGCoA
reductase activity is not required for
gamma-tocotrienol induced apoptosis. These results demonstrate that ER stress apoptotic signaling is associated with
gamma-tocotrienol-induced apoptosis in +SA mammary
tumor cells.